BRPI1009849A2 - forma cristalina molecular, uso da forma molecular, e, método para preparar um crsital molecular. - Google Patents
forma cristalina molecular, uso da forma molecular, e, método para preparar um crsital molecular.Info
- Publication number
- BRPI1009849A2 BRPI1009849A2 BRPI1009849A BRPI1009849A BRPI1009849A2 BR PI1009849 A2 BRPI1009849 A2 BR PI1009849A2 BR PI1009849 A BRPI1009849 A BR PI1009849A BR PI1009849 A BRPI1009849 A BR PI1009849A BR PI1009849 A2 BRPI1009849 A2 BR PI1009849A2
- Authority
- BR
- Brazil
- Prior art keywords
- molecular
- preparing
- crystalline form
- molecular material
- crystalline
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/4709—Non-condensed quinolines and containing further heterocyclic rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D223/00—Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom
- C07D223/02—Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom not condensed with other rings
- C07D223/06—Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom not condensed with other rings with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D223/12—Nitrogen atoms not forming part of a nitro radical
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/10—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing aromatic rings
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Epidemiology (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US16322309P | 2009-03-25 | 2009-03-25 | |
| US12/723,047 US8481526B2 (en) | 2009-03-25 | 2010-03-12 | Fluoroquinolone carboxylic acid molecular crystals |
| PCT/US2010/027812 WO2010111116A1 (en) | 2009-03-25 | 2010-03-18 | Fluoroquinolone carboxylic acid molecular crystals |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| BRPI1009849A2 true BRPI1009849A2 (pt) | 2016-03-15 |
Family
ID=42244878
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BRPI1009849A BRPI1009849A2 (pt) | 2009-03-25 | 2010-03-18 | forma cristalina molecular, uso da forma molecular, e, método para preparar um crsital molecular. |
Country Status (11)
| Country | Link |
|---|---|
| US (2) | US8481526B2 (pt) |
| EP (1) | EP2411369A1 (pt) |
| JP (1) | JP2012521433A (pt) |
| KR (1) | KR20110122202A (pt) |
| CN (1) | CN102369189B (pt) |
| AR (1) | AR075926A1 (pt) |
| BR (1) | BRPI1009849A2 (pt) |
| CA (1) | CA2756769A1 (pt) |
| MX (1) | MX2011009758A (pt) |
| TW (1) | TWI468394B (pt) |
| WO (1) | WO2010111116A1 (pt) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP3922241B1 (en) | 2013-02-01 | 2023-11-15 | Celator Pharmaceuticals, Inc. | Remote loading of sparingly water-soluble drugs into liposomes |
| EP3177269A4 (en) | 2014-08-04 | 2018-02-28 | Zoneone Pharma, Inc. | Remote loading of sparingly water-soluble drugs into lipid vesicles |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS5990183A (ja) | 1982-11-15 | 1984-05-24 | Sony Corp | カ−ド |
| JPS61225181A (ja) | 1986-02-04 | 1986-10-06 | Kyorin Pharmaceut Co Ltd | キノロンカルボン酸誘導体及びその製造方法 |
| JPS6490183A (en) | 1987-09-30 | 1989-04-06 | Kyorin Seiyaku Kk | Production of quinolonecarboxylic acid derivative |
| JP2613139B2 (ja) * | 1990-07-19 | 1997-05-21 | エスエス製薬 株式会社 | キノロンカルボン酸誘導体 |
| US6699492B2 (en) * | 1999-03-31 | 2004-03-02 | Insite Vision Incorporated | Quinolone carboxylic acid compositions and related methods of treatment |
| JP4290381B2 (ja) | 2002-04-11 | 2009-07-01 | 学校法人 聖マリアンナ医科大学 | ピリドンカルボン酸化合物含有エマルション |
| WO2008045673A2 (en) * | 2006-10-06 | 2008-04-17 | Bausch & Lomb Incorporated | Quinolone carboxylic acids, derivatives thereof, processes for its preparation and its use as antibacterial agents |
| US7632944B2 (en) * | 2007-01-24 | 2009-12-15 | Bausch & Lomb Incorporated | Quinolone carboxylic acids, derivatives thereof, and methods of making and using same |
| US8415342B2 (en) | 2008-10-29 | 2013-04-09 | Bausch & Lomb Incorporated | Besifloxacin ophthalmic composition for the treatment or control of infection |
-
2010
- 2010-03-12 US US12/723,047 patent/US8481526B2/en active Active
- 2010-03-18 KR KR1020117022456A patent/KR20110122202A/ko not_active Application Discontinuation
- 2010-03-18 CN CN201080013683.4A patent/CN102369189B/zh active Active
- 2010-03-18 EP EP10714397A patent/EP2411369A1/en not_active Withdrawn
- 2010-03-18 JP JP2012502123A patent/JP2012521433A/ja active Pending
- 2010-03-18 BR BRPI1009849A patent/BRPI1009849A2/pt not_active Application Discontinuation
- 2010-03-18 WO PCT/US2010/027812 patent/WO2010111116A1/en active Application Filing
- 2010-03-18 MX MX2011009758A patent/MX2011009758A/es active IP Right Grant
- 2010-03-18 CA CA2756769A patent/CA2756769A1/en not_active Abandoned
- 2010-03-23 AR ARP100100928A patent/AR075926A1/es not_active Application Discontinuation
- 2010-03-24 TW TW99108717A patent/TWI468394B/zh active
-
2013
- 2013-03-14 US US13/826,469 patent/US8604020B2/en active Active
Also Published As
| Publication number | Publication date |
|---|---|
| MX2011009758A (es) | 2011-09-29 |
| KR20110122202A (ko) | 2011-11-09 |
| WO2010111116A1 (en) | 2010-09-30 |
| CA2756769A1 (en) | 2010-09-30 |
| JP2012521433A (ja) | 2012-09-13 |
| TWI468394B (zh) | 2015-01-11 |
| US8481526B2 (en) | 2013-07-09 |
| CN102369189A (zh) | 2012-03-07 |
| US8604020B2 (en) | 2013-12-10 |
| EP2411369A1 (en) | 2012-02-01 |
| US20130252946A1 (en) | 2013-09-26 |
| CN102369189B (zh) | 2014-12-31 |
| AR075926A1 (es) | 2011-05-04 |
| US20100311731A1 (en) | 2010-12-09 |
| TW201038536A (en) | 2010-11-01 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| BRPI1010775A2 (pt) | composição, método para preparar uma composição, e, uso de uma composição. | |
| BRPI0912194A2 (pt) | Adoçante, método para a preparação e adoçante e aplicações do mesmo | |
| BRPI0917196A2 (pt) | método para a preparação de um complexo, e, forma cristalina de um composto. | |
| BRPI1014700A2 (pt) | composição de revestimento e método para a fabricação e uso da mesma. | |
| BRPI0908092A2 (pt) | Edulcorante, método para preparar uma composição edulcorante, e, composição edulcorante | |
| BR112012003804A2 (pt) | Curativo para ferimentos, uso do mesmo, e, método para formar um curativo para ferimentos. | |
| BRPI1011764A2 (pt) | composição farmacêutica, e, método para preparar uma composição farmacêutica | |
| BRPI0912384A2 (pt) | composição, e, método para preparar uma composição | |
| BRPI0909691A8 (pt) | composto, método para preparar um composto, e, composição farmacêutica | |
| BRPI0914918A2 (pt) | forma de dosagem farmacêutica, e, método para preparar uma forma de dosagem sólida. | |
| BRPI1014606A2 (pt) | Maltotriosil transferase, processo para produção e uso da mesma | |
| BR112013006092A2 (pt) | laminado, matéria-prima do laminado, método para preparação de um laminado e uso do laminado | |
| BRPI1014035A2 (pt) | método para contracepção. | |
| BRPI1015095A2 (pt) | composição, processos para preparar uma composição e um material de poli-isocianurato , e, material de poli-isocianurato | |
| BRPI1010309A2 (pt) | método para produzir um artigo a base de pó. | |
| BRPI0916787A2 (pt) | artigo, e, método para fabricar um artigo | |
| BRPI1014547A2 (pt) | composto, e, processo para preparar um composto. | |
| BRPI0911554A2 (pt) | Microemulsão, processo para a preparação de uma microemulsão, e, uso da microemulsão. | |
| BRPI0922173A2 (pt) | preparação farmacêutica, e, método para preparar uma preparação farmacêutica | |
| BRPI0907391A2 (pt) | Método para a preparação de um formador de escória espumante, produto e uso do mesmo | |
| BRPI1011888A2 (pt) | processo para preparar um composto, e, composição. | |
| BRPI0911770A2 (pt) | Método para produzir produtos químicos finos, microorganismo recombinante, uso do mesmo, e, método para preparar um composto | |
| BRPI1010127A2 (pt) | "composição, método para produzir um copoliéster, método para produzir um artigo espumado e artigo espumado" | |
| BRPI0918633A2 (pt) | método para calcinar matérias-primas. | |
| BR112012001628A2 (pt) | base dobrável para mostradores. |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| B07D | Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette] | ||
| B06F | Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette] | ||
| B07E | Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette] |
Free format text: NOTIFICACAO DE ANUENCIA RELACIONADA COM O ART 229 DA LPI |
|
| B06U | Preliminary requirement: requests with searches performed by other patent offices: procedure suspended [chapter 6.21 patent gazette] | ||
| B11B | Dismissal acc. art. 36, par 1 of ipl - no reply within 90 days to fullfil the necessary requirements |